Cafotrex 5 Tablet: Methotrexate IP 5 mg - Dual-Action Specialty Therapy

Name: Cafotrex 5 : Methotrexate 5 mg Tablet
Brand: Cafotrex 5 Tablet
Rating: 4.8 (150 reviews)

Mechanism of Action: Folic Acid Antagonism and Cellular Proliferation Control

Primary Oncology Use: Maintenance Therapy for Acute Lymphoblastic Leukemia (ALL)

High-Volume Specialty Applications: Psoriasis and Rheumatoid Arthritis (RA)

Ensuring Bioavailability and Patient Safety with IP Grade Methotrexate

Secure Your Monopoly: Cafotrex 5 PCD Pharma Franchise in Chronic & Oncology Care

Home/Products /methotrexate-ip-5-mg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Diagram illustrating Methotrexate blocking the DHFR enzyme

Low-dose oral therapy for severe Rheumatoid Arthritis (RA)

Oncology PCD Pharma franchise marketing visual for Methotrexate

Cafotrex 5 Tablet (Methotrexate IP) Dosing Schedule and Patient Counseling PDF

Cafotrex 5 Tablet

Composition : Methotrexate IP 5 mg Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Contact For Business Query

Cafotrex 5 Tablet (Methotrexate IP 5 mg) is a globally recognized anti-metabolite and immunosuppressant essential in both specialized oncology and chronic autoimmune care. Its versatility makes it a perpetually high-demand product in the specialty medicine market.

Mechanism and Impact:Methotrexate works as a folic acid antagonist by inhibiting the enzyme dihydrofolate reductase (DHFR). This action prevents the synthesis of DNA, RNA, and proteins, thereby slowing down the rapid proliferation of two types of cells:

Cancer Cells: Essential for cancer therapy (e.g., ALL maintenance, Choriocarcinoma).
Immune and Skin Cells: Controls the hyperactive cell turnover seen in severe autoimmune conditions (e.g., severe psoriasis and active rheumatoid arthritis).

Key Therapeutic Uses:

Oncology: Crucial for the maintenance phase of ALL and for treating certain solid tumors and lymphomas.
Autoimmune: The standard, low-dose regimen for managing severe, active Rheumatoid Arthritis and refractory Psoriasis.

We offer an exclusive PCD Pharma Franchise opportunity for Cafotrex 5, giving partners a profitable, dual-target entry into both the oncology and specialty autoimmune sectors.

About the Product

Cancer Cells: Essential for cancer therapy (e.g., ALL maintenance, Choriocarcinoma).
Immune and Skin Cells: Controls the hyperactive cell turnover seen in severe autoimmune conditions (e.g., severe psoriasis and active rheumatoid arthritis).

Key Therapeutic Uses:

Oncology: Crucial for the maintenance phase of ALL and for treating certain solid tumors and lymphomas.
Autoimmune: The standard, low-dose regimen for managing severe, active Rheumatoid Arthritis and refractory Psoriasis.

We offer an exclusive PCD Pharma Franchise opportunity for Cafotrex 5, giving partners a profitable, dual-target entry into both the oncology and specialty autoimmune sectors.

May cause nausea, vomiting, mouth ulcers, fatigue, dizziness, and elevated liver enzymes. Long-term use may lead to bone marrow suppression, liver toxicity, and lung complications. Regular monitoring is essential.

Rheumatoid arthritis and other inflammatory joint disorders Psoriasis (severe, recalcitrant forms) Certain cancers like acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma As part of chemotherapy regimens or in low doses for autoimmune disease management

To be taken only under strict medical supervision. Avoid alcohol to prevent liver toxicity. Contraindicated in pregnancy – may cause birth defects. Routine blood tests required to monitor blood counts, liver, and kidney function. Folic acid supplementation may be advised to reduce side effects.

Store at room temperature (below 25°C) in a cool, dry place, away from light and moisture. Keep out of reach of children. Do not use if the tablet appears damaged or discolored.